Drug profile · INN
niraparib tosylate
ZEJULA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
niraparib tosylate (ZEJULA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN niraparib tosylate
Brand ZEJULA
Route ORAL
Formulation CAPSULE
Frequently asked questions
What is niraparib tosylate?
niraparib tosylate (ZEJULA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for niraparib tosylate?
ZEJULA is a marketed brand name for niraparib tosylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of niraparib tosylate?
niraparib tosylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.